Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Bard avaulta infection and dangers 4

199 views

Published on

Over the past three years, the FDA has received more than 1,000 reports from nine different surgical mesh manufacturers of complications with their devices

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Bard avaulta infection and dangers 4

  1. 1. Bard Avaulta Infection and Dangers
  2. 2. Over the past three years, the FDA has received more than1,000 reports from nine different surgical meshmanufacturers of complications with their devices. Thesedevices, used to repair Pelvic Organ Prolapse and StressUrinary Incontinence, were introduced on the market toalleviate the pain and discomfort experienced by thewomen suffering from these conditions, however the FDAreports suggest otherwise.
  3. 3. Surgical mesh functions by supporting the bladder, andreinforcing the muscles that control the flow of urine fromthe body for treatment of Stress Urinary Incontinence. Forprolapse, the mesh acts as a barrier to hold the pelvicorgans in place, preventing any painful slipping from theirnormal place in the pelvis. The mesh is inserted throughthe vagina for both of these procedures, using minimallyinvasive techniques.
  4. 4. What is proving to not be minimally invasive are the seriousside effects being reported by patients who have had thissurgery performed. Complications being reported includeerosion of vaginal tissue, pain, and additional urinaryproblems. Visit Avaulta vaginal mesh for more info. Themost common complication reported to the FDA is seriousinfection.
  5. 5. Infections from transvaginal placement of surgical meshcan occur in one of two ways. First, an infection may becaused by bowel, bladder, or blood vessel perforation,which occurs during insertion of the surgical mesh. Second,the mesh design may inhibit surrounding tissue fromreceiving nutrients and oxygen, causing impaired healingthat can lead to an infection.
  6. 6. A surgical mesh recall has not yet been issued for BardAvaulta or other surgical mesh devices, as the FDA has notyet determined whether specific characteristics put somepatients at an increased risk for transvaginal surgical meshinfection. Some contributing factors to complications includethe patients overall health, the transvaginal surgical meshmaterial, the size and shape of the surgical mesh, thesurgical technique used, concomitant proceduresundertaken (e.g. hysterectomy), and possibly estrogenstatus.http://www.consumerinjuries.com/avaulta-vaginal-mesh/
  7. 7. A surgical mesh recall has not yet been issued for BardAvaulta or other surgical mesh devices, as the FDA has notyet determined whether specific characteristics put somepatients at an increased risk for transvaginal surgical meshinfection. Some contributing factors to complications includethe patients overall health, the transvaginal surgical meshmaterial, the size and shape of the surgical mesh, thesurgical technique used, concomitant proceduresundertaken (e.g. hysterectomy), and possibly estrogenstatus.http://www.consumerinjuries.com/avaulta-vaginal-mesh/

×